CISPLATIN INJECTION SOLUTION Kanāda - angļu - Health Canada

cisplatin injection solution

strides pharma canada inc - cisplatin - solution - 1mg - cisplatin 1mg - antineoplastic agents

CISPLATIN INJECTION SOLUTION Kanāda - angļu - Health Canada

cisplatin injection solution

teva canada limited - cisplatin - solution - 1.0mg - cisplatin 1.0mg - antineoplastic agents

CISPLATIN INJECTION SOLUTION Kanāda - angļu - Health Canada

cisplatin injection solution

fresenius kabi canada ltd - cisplatin - solution - 1mg - cisplatin 1mg - antineoplastic agents

CISPLATIN INJECTION BP SOLUTION Kanāda - angļu - Health Canada

cisplatin injection bp solution

hikma canada limited - cisplatin - solution - 1mg - cisplatin 1mg

CISPLATIN INJECTION, MYLAN STD. SOLUTION Kanāda - angļu - Health Canada

cisplatin injection, mylan std. solution

mylan pharmaceuticals ulc - cisplatin - solution - 1mg - cisplatin 1mg - antineoplastic agents

CISPLATIN INJECTION BP SOLUTION Kanāda - angļu - Health Canada

cisplatin injection bp solution

pfizer canada ulc - cisplatin - solution - 1mg - cisplatin 1mg - antineoplastic agents

DBL CISPLATIN 100mg/100mL Injection Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

dbl cisplatin 100mg/100ml injection

pfizer australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; water for injections; sodium chloride - cisplatin injection is indicated for the palliative treatment of metastatic non-seminomatous germ cell carcinoma, advanced-stage refractory ovarian carcinoma, advanced-stage refractory bladder carcinoma and refractory squamous cell carcinoma of the head and neck. it may be used as a single agent or in combination with other chemotherapeutic agents. it may be employed, in appropriate circumstances, in addition to other modalities, eg radiotherapy or surgery.

DBL CISPLATIN 50mg/50mL Injection Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

dbl cisplatin 50mg/50ml injection

pfizer australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, solution - excipient ingredients: sodium chloride; mannitol; water for injections - cisplatin injection is indicated for the palliative treatment of metastatic non-seminomatous germ cell carcinoma, advanced-stage refractory ovarian carcinoma, advanced-stage refractory bladder carcinoma and refractory squamous cell carcinoma of the head and neck. it may be used as a single agent or in combination with other chemotherapeutic agents. it may be employed, in appropriate circumstances, in addition to other modalities, eg radiotherapy or surgery.

CISPLATIN injection, solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

cisplatin injection, solution

fresenius kabi usa, llc - cisplatin (unii: q20q21q62j) (cisplatin - unii:q20q21q62j) -

CISPLATIN injection, solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

cisplatin injection, solution

apotex corp. - cisplatin (unii: q20q21q62j) (cisplatin - unii:q20q21q62j) -